Scribble

Price Momentum

MEDS is trading near the bottom of its 52-week range and below its 200-day simple moving average.
Price change

The price of MEDS shares has decreased $0.04 since the market last closed. This is a 3.28% drop.
Closed at $1.18.

The stock has since risen $0.02 in after-hours trading.

Key terms

DataMeds AI, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Market cap: $5.30M

A market capitalization up to $300 million places MEDS in the micro-capitalization category.

Key terms

Smart score

Nov 05, 2026 9:51am ET DataMEDS AI signs MOU to deploy Health Lives Here mobile application by TipRanks Nov 05, 2026 6:38am ET DataMeds AI Terminates Letter of Intent Amid Market Conditions by TipRanks Nov 03, 2026 6:25pm ET DataMEDS announces termination of second amended and restated letter of intent by TipRanks Nov 02, 2026 6:15am ET DataMEDS AI enters pact for commercial supply of six peptides by TipRanks Oct 26, 2026 5:30pm ET DataMeds AI Pursues Transformative Telehealth IP Acquisition by TipRanks Oct 22, 2026 8:17am ET Datavault signs non-binding LOI to acquire 19.9% stake in DataMEDS AI by TipRanks Oct 22, 2026 7:45am ET DataMEDS AI enters amended, restated LOI to license, acquire IP by TipRanks Oct 20, 2026 9:37am ET DataMeds AI Regains Nasdaq Equity Compliance Status by TipRanks Oct 16, 2026 5:52pm ET DataMeds AI Licenses REBOOT Platform, Issues Equity by TipRanks Oct 13, 2026 5:48pm ET DataMeds AI Restructures Equity and Forms Licensing Partnership by TipRanks Sep 17, 2026 6:02pm ET DataMeds AI Settles Litigation, Strengthens Balance Sheet by TipRanks Sep 17, 2026 9:45am ET DataMeds AI Inc trading resumes by TipRanks Sep 17, 2026 9:35am ET DataMeds AI Inc trading halted, volatility trading pause by TipRanks Sep 17, 2026 8:28am ET These 3 Penny Stocks Are on Investors’ Radar Today — Here’s Why by TipRanks Sep 16, 2026 5:28pm ET DataMeds AI Acquires Helomics to Expand Cancer Platform by TipRanks Sep 15, 2026 4:15pm ET DataMEDS AI acquires Helomics subsidiary from Axe Compute for $1.5M by TipRanks Sep 15, 2026 2:38pm ET Why Is DataMeds AI Stock (MEDS) Up Nearly 200% Today? by TipRanks Sep 15, 2026 9:00am ET Axe Compute sells Helomics to DataMEDS AI, terms undisclosed by TipRanks Aug 17, 2026 12:31pm ET Midday Fly By: Equinor buys stake in Energy Center, Nvidia to invest $1.5B in SB by TipRanks Aug 17, 2026 9:15am ET DataMEDS AI reports Q2 EPS ($7.13) vs. ($5.40) last year by TipRanks Aug 14, 2026 6:22pm ET DataMEDS AI delays quarterly SEC filing by TipRanks Aug 14, 2026 5:25pm ET DataMeds AI Announces Token-Based Shareholder Distribution Plan by TipRanks Aug 10, 2026 8:41am ET DataMEDS AI renames pharmacy subsidiaries under Corexa Health division by TipRanks

1-year income & revenue

Total revenue: $23.34M (1Y), $1.78M (Q2)

Total Revenue increased 28.73% since last year and increased 14.13% since last quarter.
Net income: -$101.27M (1Y), -$18.36M (Q2)

Net Income decreased 1377.12% since last year and decreased 137.17% since last quarter.
Earnings per share: -$49.98 (1Y), -$7.13 (Q2)

EPS decreased 657.38% since last year and decreased 119.96% since last quarter.

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

How competitors are chosen

MEDS's competitors are included in the Distribution Services sector and Medical Distributors group
Market cap: $5.30M

A market capitalization up to $300 million places MEDS in the micro-capitalization category.